Page 4 - Veeral Sheth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Veeral sheth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Veeral Sheth Today - Breaking & Trending Today

Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October

Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic RetinopathyFARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced presentations featuring results from the ZETA-1 Phase 2 Trial of APX3330 at the 23rd Euretina Congress to take plac ....

United States , New York , Noord Holland , Veeral Sheth , Corey Davis , Ocuphire Pharma , Rick Rodgers , Viatris Inc , Amsterdam Convention Center , Ocuphire Pharma Inc , Retina Society Scientific Meeting , Drug Administration , Euretina Congress , Presentations Will Feature Data From , Annual Retina Society Scientific Meeting , Daily Treatment , Safety Results , Paper Session , Tolerability Results , Intercontinental New York , Non Proliferative Diabetic Retinopathy , Proliferative Diabetic Retinopathy , Sci Advisors , Diabetic Retinopathy , Ocuphire Pharma , Efractive Eye Disorders ,

New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD

Host Veeral Sheth, MD is joined by Megan Baldwin, PhD, CEO and managing director of Opthea Limited, to discuss sozinibercept, a novel recombinant “trap” fusion protein targeting inhibition of VEGF-C and VEGF-D. ....

United States , Veeral Sheth , Connor Iapoce , Megan Baldwin , Drug Administration , American Society For Retina Specialists , New Insight , Opthea Limited , American Society , Retina Specialists , Annual Meeting , Apple Podcasts ,

High Dose Aflibercept as Emerging Therapy for Retinal Diseases

Experts discuss the recent PULSAR and PHOTON studies with high dose aflibercept (8mg) and how they educate patients about this treatment approach. ....

Ehsan Rahimy , Veeral Sheth , Jonathan Jonisch , Anti Vegf , Age Related Macular Degeneration , Macular Degeneration , Diabetic Macular Edema , Patient Education ,

Step Therapy for Patients With DME

Experts discuss insurer mandated step therapy and how to navigate treatment options for patients with diabetic macular edema (DME). ....

United States , Jonathan Jonisch , Veeral Sheth , Ehsan Rahimy , Bali Khan , American Academy Of Ophthalmology , American Academy , Medicare Advantage , Diabetic Macular Edema , Age Related Macular Degeneration , Anti Vegf , First Line , Step Therapy ,

Efficacy of Faricimab in Clinical Trails

Experts discuss clinical trials on the efficacy of faricimab and how they utilize this therapy in their practice. ....

Jonathan Jonisch , Veeral Sheth , Ehsan Rahimy , Bali Khan , Holy Grail , Anti Vegf , Age Related Macular Degeneration , Macular Degeneration , Diabetic Macular Edema ,